UK-based Juvenescence, a clinical stage AI-enabled biotech company, has secured a total of $76 million in the first-close of ...

UK-based PureTech Health (LSE: PRTC) delivered a late-breaking, oral presentation at the 2025 American Thoracic Society (ATS) International Conference in San Francisco. The presentation provided ...

US biotech Tourmaline Bio has reported topline data from a Phase II trial of its lead asset, pacibekitug, in people with chronic kidney disease (CKD) and elevated inflammation levels associated with ...

US biotech company SparX Biopharmaceutical has signed a research agreement with Mitsubishi Tanabe Pharma America aimed at ...

German antibody drug conjugate (ADC) specialist Tubulis announced that the first program from its 2023 licensing accord with ...

US healthcare giant Johnson & Johnson (NYSE: JNJ) presented long-term findings from the 24-month open-label extension of the ...

South Korean vaccine maker SK Bioscience has secured a final court victory over US pharma major Pfizer in a long-running patent dispute concerning exports of its 13-valent pneumococcal conjugate ...

Major progress has been made in delivering a more efficient and adaptable regulatory framework for clinical trials, and ...

German drugmaker Grünenthal has named Maren Thurow as its new vice president and head of global communications, stepping into ...

A week after US President Donald Trump signed an executive order to bring back the Most Favored Nation (MFN) idea he ...

Australia’s digital health sector is poised for steady expansion, with the market forecast to grow at a compound annual growth rate of around 8% through 2034, according to research from data and ...